Published December 1, 2022 | Version v2
Dataset Open

Urinary volatilome database

Authors/Creators

  • 1. Department of Electrical Engineering and Automation, Universitat Rovira i Virgili, 43007 Tarragona, Spain
  • 2. Oncology Department, Institut d'Investigació Sanitària Pere Virgili (IISPV), Spain

Description

Chemically diverse in compounds, urine can give us an insight into metabolic breakdown products from foods, drinks, drugs, environmental contaminants, endogenous waste metabolites, and bacterial by-products. Hundreds of them are volatile compounds; however, their composition has never been provided in detail, nor has the methodology used for urine volatilome untargeted analysis. Here, we summarize key elements for the untargeted analysis of urine volatilome from a comprehensive compilation of literature, including the latest reports published. Current achievements and limitations on each process step are discussed and compared. 34 studies were found retrieving all information from the urine treatment to the final results obtained. In this report, we provide the first specific urine volatilome database, consisting of 841 compounds from 80 different chemical classes. The dataset includes a summary of studies methodology described in Llambrich M, Brezmes J, Cumeras R. "The untargeted urine volatilome for biomedical applications: methodology and volatilome database". 

Files

Files (338.2 kB)

Name Size Download all
md5:786d438705c4e41147f8988c5c1b197b
133.1 kB Download
md5:1df290441a4c21195cc51424a56a2d52
205.1 kB Download

Additional details

References

  • Silva CL, Passos M, Câmara JS. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br J Cancer 2011;105:1894–904. https://doi.org/10.1038/bjc.2011.437.
  • Silva CL, Perestrelo R, Silva P, Tomás H, Câmara JS. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer. Metabolomics 2019;15:64. https://doi.org/10.1007/s11306-019-1525-2.
  • Taunk K, Taware R, More TH, Porto-Figueira P, Pereira JAM, Mohapatra R, et al. A non-invasive approach to explore the discriminatory potential of the urinary volatilome of invasive ductal carcinoma of the breast. RSC Adv 2018;8:25040–50. https://doi.org/10.1039/c8ra02083c.
  • Lima AR, Pinto J, Azevedo AI, Barros-Silva D, Jerónimo C, Henrique R, et al. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. Br J Cancer 2019;121:857–68. https://doi.org/10.1038/s41416-019-0585-4.
  • Deev V, Solovieva S, Andreev E, Protoshchak V, Karpushchenko E, Sleptsov A, et al. Prostate cancer screening using chemometric processing of GC–MS profiles obtained in the headspace above urine samples. J Chromatogr B Anal Technol Biomed Life Sci 2020;1155:122298. https://doi.org/10.1016/j.jchromb.2020.122298.
  • Khalid T, Aggio R, White P, De Lacy Costello B, Persad R, Al-Kateb H, et al. Urinary volatile organic compounds for the detection of prostate cancer. PLoS One 2015;10:1–15. https://doi.org/10.1371/journal.pone.0143283.
  • Pinto J, Amaro F, Lima AR, Carvalho-Maia C, Jerónimo C, Henrique R, et al. Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma. J Proteome Res 2021;20:3068–77. https://doi.org/10.1021/acs.jproteome.0c00936.
  • Wang D, Wang C, Pi X, Guo L, Wang Y, Li M, et al. Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma. Biomed Reports 2016;5:68–72. https://doi.org/10.3892/br.2016.686.
  • Opitz P, Herbarth O. The volatilome - Investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC). J Otolaryngol - Head Neck Surg 2018;47:1–13. https://doi.org/10.1186/s40463-018-0288-5.
  • Taware R, Taunk K, Pereira JAM, Dhakne R, Kannan N, Soneji D, et al. Investigation of urinary volatomic alterations in head and neck cancer: a non-invasive approach towards diagnosis and prognosis. Metabolomics 2017;13:111. https://doi.org/10.1007/s11306-017-1251-6.
  • de Sousa Mesquita A, Zamora-Obando HR, Neves dos Santos F, Schmidt-Filho J, Cordeiro de Lima V, D'Almeida Costa F, et al. Volatile organic compounds analysis optimization and biomarker discovery in urine of Non-Hodgkin lymphoma patients before and during chemotherapy. Microchem J 2020;159:105479. https://doi.org/10.1016/j.microc.2020.105479.
  • Hua Q, Wang L, Liu C, Han L, Zhang Y, Liu H. Volatile metabonomic profiling in urine to detect novel biomarkers for B-cell non-Hodgkin's lymphoma. Oncol Lett 2018;15:7806–16. https://doi.org/10.3892/ol.2018.8352.
  • Hanai Y, Shimono K, Matsumura K, Vachani A, Albelda S, Yamazaki K, et al. Urinary volatile compounds as biomarkers for lung cancer. Biosci Biotechnol Biochem 2012;76:679–84. https://doi.org/10.1271/bbb.110760.
  • Filipiak W, Ruzsanyi V, Mochalski P, Filipiak A, Bajtarevic A, Ager C, et al. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. J Breath Res 2012;6. https://doi.org/10.1088/1752-7155/6/3/036008.
  • Longo V, Forleo A, Ferramosca A, Notari T, Pappalardo S, Siciliano P, et al. Blood, urine and semen Volatile Organic Compound (VOC) pattern analysis for assessing health environmental impact in highly polluted areas in Italy. Environ Pollut 2021;286:117410. https://doi.org/10.1016/j.envpol.2021.117410.
  • Wang C, Feng Y, Wang M, Pi X, Tong H, Wang Y, et al. Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls. Sci Rep 2015;5:2–11. https://doi.org/10.1038/srep14744.
  • Liu D, Zhao N, Wang M, Pi X, Feng Y, Wang Y, et al. Urine volatile organic compounds as biomarkers for minimal change type nephrotic syndrome. Biochem Biophys Res Commun 2018;496:58–63. https://doi.org/10.1016/j.bbrc.2017.12.164.
  • Ligor T, Zawadzka J, Straczyński G, González Paredes RM, Wenda-Piesik A, Ratiu IA, et al. Searching for potential markers of glomerulopathy in urine by HS-SPME-GC×GC TOFMS. Molecules 2021;26. https://doi.org/10.3390/molecules26071817.
  • Statheropoulos M, Sianos E, Agapiou A, Georgiadou A, Pappa A, Tzamtzis N, et al. Preliminary investigation of using volatile organic compounds from human expired air, blood and urine for locating entrapped people in earthquakes. J Chromatogr B Anal Technol Biomed Life Sci 2005;822:112–7. https://doi.org/10.1016/j.jchromb.2005.05.028.
  • Mochalski P, Krapf K, Ager C, Wiesenhofer H, Agapiou A, Statheropoulos M, et al. Temporal profiling of human urine VOCs and its potential role under the ruins of collapsed buildings. Toxicol Mech Methods 2012;22:502–11. https://doi.org/10.3109/15376516.2012.682664.
  • Kusano M, Mendez E, Furton KG. Comparison of the Volatile Organic Compounds from Different Biological Specimens for Profiling Potential. J Forensic Sci 2013;58:29–39. https://doi.org/10.1111/j.1556-4029.2012.02215.x.
  • Cozzolino R, De Magistris L, Saggese P, Stocchero M, Martignetti A, Di Stasio M, et al. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls. Anal Bioanal Chem 2014;406:4649–62. https://doi.org/10.1007/s00216-014-7855-z.
  • Cozzolino R, De Giulio B, Marena P, Martignetti A, Günther K, Lauria F, et al. Urinary volatile organic compounds in overweight compared to normal-weight children: Results from the Italian I.Family cohort. Sci Rep 2017;7:1–14. https://doi.org/10.1038/s41598-017-15957-7.
  • Zhang S, Liu L, Steffen D, Ye T, Raftery D. Metabolic profiling of gender: Headspace-SPME/GC-MS and 1H NMR analysis of urine. Metabolomics 2012;8:323–34. https://doi.org/10.1007/s11306-011-0315-2.
  • Mack CI, Egert B, Liberto E, Weinert CH, Bub A, Hoffmann I, et al. Robust Markers of Coffee Consumption Identified Among the Volatile Organic Compounds in Human Urine. Mol Nutr Food Res 2019;63:1–12. https://doi.org/10.1002/mnfr.201801060.
  • Eshima J, Davis TJ, Bean HD, Fricks J, Smith BS. A metabolomic approach for predicting diurnal changes in cortisol. Metabolites 2020;10. https://doi.org/10.3390/metabo10050194.
  • Drabińska N, Małgorzata S, Krupa-Kozak U. Headspace Solid-Phase Microextraction Coupled with Gas Chromatography–Mass Spectrometry for the Determination of Volatile Organic Compounds in Urine. J Anal Chem 2020;75:792–801. https://doi.org/10.1134/S1061934820060088.
  • Živković Semren T, Brčić Karačonji I, Safner T, Brajenović N, Tariba Lovaković B, Pizent A. Gas chromatographic-mass spectrometric analysis of urinary volatile organic metabolites: Optimization of the HS-SPME procedure and sample storage conditions. Talanta 2018;176:537–43. https://doi.org/10.1016/j.talanta.2017.08.064.
  • Song H-N, Kim CH, Lee W-Y, Cho S-H. Simultaneous determination of volatile organic compounds with a wide range of polarities in urine by headspace solid-phase microextraction coupled to gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2017;31:613–22. https://doi.org/10.1002/rcm.7827.
  • Rocha SM, Caldeira M, Carrola J, Santos M, Cruz N, Duarte IF. Exploring the human urine metabolomic potentialities by comprehensive two-dimensional gas chromatography coupled to time of flight mass spectrometry. J Chromatogr A 2012;1252:155–63. https://doi.org/10.1016/j.chroma.2012.06.067.